Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04023877 · ClinicalTrials.gov registry record · Phase 1
A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT04023877 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 8 participants.
The verdict
NCT04023877, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The primary objective of the study is to achieve mass balance recovery of \[14C\]-radiolabel in urine and feces and to identify and quantify the main elimination pathways of E2027.
Interventions
- DRUG E2027
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-07-18 |
| Est. Completion | 2019-10-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04023877
The ClinicalTrials.gov registry entry for NCT04023877 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E2027 is the first listed.
NCT04023877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04023877 about?
NCT04023877 is a clinical study titled "A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants". The primary objective of the study is to achieve mass balance recovery of \[14C\]-radiolabel in urine and feces and to identify and quantify the main elimination pathways of E2027.
What is the current status of trial NCT04023877?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2019-07-18. Estimated completion is 2019-10-11.
What interventions are being tested in trial NCT04023877?
The interventions under investigation include: E2027 (DRUG).
Who is sponsoring clinical trial NCT04023877?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.